HCA Healthcare stock screens as undervalued across all six valuation measures on Simply Wall St, even after delivering a 52.3% return over the past five years. The company trades at a price-to-earnings ratio of about 11.9 times, well below the broader healthcare industry average of around 25.1 times and the peer group average of roughly 15.0 times. Simply Wall St's fair multiple framework suggests a P/E closer to 26.7 times given HCA Healthcare's growth, margins, size, and risks, implying a wide discount. The investment case is supported by expectations around the company's use of scale and artificial intelligence tools to support care quality, while a rising load of uninsured patients and union-related staffing pressures may weigh on profitability and investor confidence. The key question is whether HCA Healthcare can sustain earnings quality well enough for the valuation gap to close rather than become a longer-term value trap.
HCA Healthcare, Inc.Stock is undervalued per multiple valuation measures, trading at a P/E discount to industry and peers, with analyst fair value suggesting upside.